相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutational landscape of non-muscle-invasive bladder cancer
Carolyn D. Hurst et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)
Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy
Jose Batista da Costa et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Aurelie Kamoun et al.
EUROPEAN UROLOGY (2020)
Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants
Joshua I. Warrick et al.
EUROPEAN UROLOGY (2019)
Molecular Characterization of Neuroendocrine-like Bladder Cancer
Jose Batista da Costa et al.
CLINICAL CANCER RESEARCH (2019)
Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors
Yair Lotan et al.
EUROPEAN UROLOGY (2019)
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
Emil Christensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer.
Thomas W. Flaig et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Development of a translational medicine protocol for an NCTN genitourinary clinical trial: Critical steps, common pitfalls and a basic guide to translational clinical research
Joshua J. Meeks et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer
Charles C. Guo et al.
CELL REPORTS (2019)
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
Y. Loriot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Role of rebiopsy in metastatic breast cancer at progression
Manish Sharma et al.
CURRENT PROBLEMS IN CANCER (2019)
Variants and new entities of bladder cancer
Antonio Lopez-Beltran et al.
HISTOPATHOLOGY (2019)
Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition
Arlene Siefker-Radtke et al.
NATURE REVIEWS UROLOGY (2018)
Characterization of Metastatic Urothelial Carcinoma via Comprehensive Genomic Profiling of Circulating Tumor DNA
Neeraj Agarwal et al.
CANCER (2018)
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications
Daniel H. Hovelson et al.
EUROPEAN UROLOGY (2018)
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma
Sumit Isharwal et al.
HUMAN PATHOLOGY (2018)
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
Henning Reis et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases
Gottfrid Sjodahl et al.
MODERN PATHOLOGY (2018)
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations
Sumanta K. Pal et al.
CANCER DISCOVERY (2018)
Precision medicine and bladder cancer heterogeneity
Guofeng Ma et al.
BULLETIN DU CANCER (2018)
Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology
Lars Dyrskjot et al.
CURRENT OPINION IN UROLOGY (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study
Andrea Necchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Lineage tracking reveals dynamic relationships of T cells in colorectal cancer
Lei Zhang et al.
NATURE (2018)
Therapy resistance mediated by cancer stem cells
Teresa Bernadette Steinbichler et al.
SEMINARS IN CANCER BIOLOGY (2018)
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Matthew T. Chang et al.
CLINICAL CANCER RESEARCH (2018)
Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer
Ivana Bratic Hench et al.
FRONTIERS IN MEDICINE (2018)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
Roland Seiler et al.
EUROPEAN UROLOGY (2017)
Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study
Lars Dyrskjot et al.
EUROPEAN UROLOGY (2017)
Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset
Woonyoung Choi et al.
EUROPEAN UROLOGY (2017)
Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes
Jasmine A. McQuerry et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification
Gottfrid Sjodahl et al.
JOURNAL OF PATHOLOGY (2017)
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Padmanee Sharma et al.
LANCET ONCOLOGY (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?
James P. Solomon et al.
UROLOGY (2017)
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Chantal Pauli et al.
CANCER DISCOVERY (2017)
Principles of Reconstructing the Subclonal Architecture of Cancers
Stefan C. Dentro et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Genomic Activation of PPARG Reveals a Candidate Therapeutic Axis in Bladder Cancer
Jonathan T. Goldstein et al.
CANCER RESEARCH (2017)
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency
Carolyn D. Hurst et al.
CANCER CELL (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Gillian Vandekerkhove et al.
CLINICAL CANCER RESEARCH (2017)
Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance
P. C. Barata et al.
ANNALS OF ONCOLOGY (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment
A. R. Thierry et al.
ANNALS OF ONCOLOGY (2017)
Using circulating cell-free DNA to monitor personalized cancer therapy
Michael Oellerich et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients
Cloud P. Paweletz et al.
CLINICAL CANCER RESEARCH (2016)
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Mariangela Russo et al.
CANCER DISCOVERY (2016)
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
D. Pouessel et al.
ANNALS OF ONCOLOGY (2016)
Sarcomatoid Urothelial Carcinoma of the Bladder Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition
Joseph Sanfrancesco et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard et al.
CANCER CELL (2016)
Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
Philippe Lamy et al.
CANCER RESEARCH (2016)
Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer
Charles Chuanhai Guo et al.
EUROPEAN UROLOGY (2016)
Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition
Ana Collazo-Lorduy et al.
EUROPEAN UROLOGY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours
Peter A. Humphrey et al.
EUROPEAN UROLOGY (2016)
APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication
Vladimir B. Seplyarskiy et al.
GENOME RESEARCH (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma
Mathilde B. H. Thomsen et al.
MOLECULAR ONCOLOGY (2016)
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer
Hikmat A. Al-Ahmadie et al.
NATURE GENETICS (2016)
Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer
Andrew McPherson et al.
NATURE GENETICS (2016)
Clonal evolution of chemotherapy-resistant urothelial carcinoma
Bishoy M. Faltas et al.
NATURE GENETICS (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
The APOBEC Protein Family: United by Structure, Divergent in Function
Jason D. Salter et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
John M. Findlay et al.
NATURE COMMUNICATIONS (2016)
APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication
James I. Hoopes et al.
CELL REPORTS (2016)
Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder
Eric Vail et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2015)
A case of heterogeneous sensitivity to panitumumab in cetuximab-refractory colorectal adenocarcinoma metastases
Eric Marks et al.
CANCER BIOLOGY & THERAPY (2015)
Assessment of genomic alterations in bladder adenocarcinoma and urachal adenocarcinoma
E. Jordan et al.
EUROPEAN JOURNAL OF CANCER (2015)
Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder
Philip H. Kim et al.
EUROPEAN UROLOGY (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity
Bartlomiej Waclaw et al.
NATURE (2015)
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
Charles Swanton et al.
CANCER DISCOVERY (2015)
APOBEC-Induced Cancer Mutations Are Uniquely Enriched in Early-Replicating, Gene-Dense, and Active Chromatin Regions
Marat D. Kazanov et al.
CELL REPORTS (2015)
Distinguishing Nested Variants of Urothelial Carcinoma From Benign Mimickers by TERT Promoter Mutation
Minghao Zhong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi et al.
CANCER CELL (2014)
A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
Jeffrey S. Ross et al.
CLINICAL CANCER RESEARCH (2014)
Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity
Elizabeth R. Plimack et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Branched evolution and intratumor heterogeneity of urothelial carcinoma of the bladder.
Eugene K. Cha et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Marco Gerlinger et al.
NATURE GENETICS (2014)
Plasmacytoid Bladder Cancer: Variant Histology With Aggressive Behavior and a New Mode of Invasion Along Fascial Planes
Hristos Z. Kaimakliotis et al.
UROLOGY (2014)
Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer
Iver Nordentoft et al.
CELL REPORTS (2014)
AID and APOBECs span the gap between innate and adaptive immunity
Arnaud Moris et al.
FRONTIERS IN MICROBIOLOGY (2014)
Unraveling the clonal hierarchy of somatic genomic aberrations
Davide Prandi et al.
GENOME BIOLOGY (2014)
High-Risk Human Papillomavirus DNA Detected in Primary Squamous Cell Carcinoma of Urinary Bladder
Jennifer Rose Chapman-Fredricks et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
APOBEC3 Cytidine Deaminases in Double-Strand DNA Break Repair and Cancer Promotion
Roni Nowarski et al.
CANCER RESEARCH (2013)
Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer
Gopa Iyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The Impact of Histological Reclassification during Pathology Re-Review-Evidence of a Will Rogers Effect in Bladder Cancer?
Brian J. Linder et al.
JOURNAL OF UROLOGY (2013)
Plasmacytoid Urothelial Carcinoma, a Chemosensitive Cancer with Poor Prognosis, and Peritoneal Carcinomatosis
Farshid Dayyani et al.
JOURNAL OF UROLOGY (2013)
Evidence for APOBEC3B mutagenesis in multiple human cancers
Michael B. Burns et al.
NATURE GENETICS (2013)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital
Rajal B. Shah et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjodahl et al.
CLINICAL CANCER RESEARCH (2012)
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
Nicholas A. Saunders et al.
EMBO MOLECULAR MEDICINE (2012)
A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Joshua J. Meeks et al.
EUROPEAN UROLOGY (2012)
Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection
Elen B. Blochin et al.
MODERN PATHOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Functions and regulation of the APOBEC family of proteins
Harold C. Smith et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
Levi A. Garraway et al.
CANCER DISCOVERY (2012)
Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours
Achim Fleischmann et al.
EUROPEAN UROLOGY (2011)
The plasmacytoid carcinoma of the bladder-rare variant of aggressive urothelial carcinoma
Bastian Keck et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization
Christina B. Ching et al.
MODERN PATHOLOGY (2011)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
Plasmacytoid Urothelial Carcinoma Detailed Analysis of Morphology With Clinicopathologic Correlation in 17 Cases
Priya Nigwekar et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Urachal Carcinoma A Clinicopathologic Analysis of 24 Cases With Outcome Correlation
Anuradha Gopalan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair
Alfredo Blanes et al.
HUMAN PATHOLOGY (2009)
Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications
Mahul B. Amin
MODERN PATHOLOGY (2009)
Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation
M-T Sung et al.
JOURNAL OF PATHOLOGY (2007)
APOBEC3 inhibits mouse mammary tumour virus replication in vivo
Chioma M. Okeoma et al.
NATURE (2007)
A molecular signature in superficial bladder carcinoma predicts clinical outcome
L Dyrskjot et al.
CLINICAL CANCER RESEARCH (2005)
Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein
H Nassar et al.
MODERN PATHOLOGY (2004)
Florid von Brunn nests mimicking urothelial carcinoma - A morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma
KE Volmar et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
HB Grossman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
